Product
SYH2043
1 clinical trial
1 indication
Indication
Advanced Malignant TumorsClinical trial
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Preliminary Efficacy of SYH2043 in Patients With Advanced Malignant TumorsStatus: Not yet recruiting, Estimated PCD: 2026-02-01